293T-RNF2 site5-crDdCBE1.2-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE1.2-Rep3

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE1.3-Rep1

status: PUBLIC

characteristic: External Id

text: ShanghaiTech University

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

tag: attribute

text: Homo sapiens

characteristic: organism

text: 293T-RNF2 site5-crDdCBE1.3-Rep1

text: Human sample from Homo sapiens

characteristic: title


293T-RNF2 site5-crDdCBE1.3-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE1.3-Rep2

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE1.3-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE1.3-Rep3

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE1.4-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE1.4-Rep1

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE1.4-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE1.4-Rep2

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE1.4-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE1.4-Rep3

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE1.5-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE1.5-Rep1

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE1.5-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE1.5-Rep2

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE1.5-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE1.5-Rep3

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.0-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.0-Rep1

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.0-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.0-Rep2

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.0-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.0-Rep3

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.1-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.1-Rep1

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.1-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.1-Rep2

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.1-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.1-Rep3

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.2-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.2-Rep1

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.2-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.2-Rep2

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.2-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.2-Rep3

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.3-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.3-Rep1

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.3-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.3-Rep2

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.3-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.3-Rep3

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.4-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.4-Rep1

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.4-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.4-Rep2

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.4-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.4-Rep3

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.5-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.5-Rep1

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.5-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.5-Rep2

text: Human sample from Homo sapiens


293T-RNF2 site5-crDdCBE2.5-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-RNF2 site5-crDdCBE2.5-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.0-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.0-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.0-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.0-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.0-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.0-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.1-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.1-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.1-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.1-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.1-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.1-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.2-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.2-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.2-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.2-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.2-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.2-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.3-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.3-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.3-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.3-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.3-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.3-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.4-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.4-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.4-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.4-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.4-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.4-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.5-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.5-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.5-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.5-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE1.5-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE1.5-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.0-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.0-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.0-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.0-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.0-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.0-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.1-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.1-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.1-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.1-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.1-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.1-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.2-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.2-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.2-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.2-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.2-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.2-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.3-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.3-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.3-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.3-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.3-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.3-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.4-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.4-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.4-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.4-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.4-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.4-Rep3

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.5-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.5-Rep1

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.5-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.5-Rep2

text: Human sample from Homo sapiens


293T-ATM site1-crDdCBE2.5-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site1-crDdCBE2.5-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.0-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.0-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.0-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.0-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.0-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.0-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.1-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.1-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.1-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.1-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.1-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.1-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.2-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.2-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.2-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.2-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.2-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.2-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.3-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.3-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.3-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.3-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.3-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.3-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.4-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.4-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.4-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.4-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.4-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.4-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.5-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.5-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.5-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.5-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE1.5-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE1.5-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.0-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.0-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.0-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.0-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.0-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.0-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.1-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.1-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.1-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.1-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.1-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.1-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.2-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.2-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.2-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.2-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.2-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.2-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.3-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.3-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.3-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.3-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.3-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.3-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.4-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.4-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.4-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.4-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.4-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.4-Rep3

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.5-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.5-Rep1

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.5-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.5-Rep2

text: Human sample from Homo sapiens


293T-ATM site2-crDdCBE2.5-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-ATM site2-crDdCBE2.5-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.0-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.0-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.0-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.0-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.0-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.0-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.1-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.1-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.1-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.1-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.1-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.1-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.2-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.2-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.2-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.2-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.2-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.2-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.3-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.3-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.3-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.3-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.3-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.3-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.4-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.4-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.4-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.4-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.4-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.4-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.5-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.5-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.5-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.5-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE1.5-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE1.5-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.0-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.0-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.0-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.0-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.0-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.0-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.1-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.1-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.1-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.1-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.1-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.1-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.2-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.2-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.2-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.2-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.2-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.2-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.3-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.3-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.3-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.3-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.3-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.3-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.4-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.4-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.4-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.4-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.4-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.4-Rep3

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.5-Rep1

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.5-Rep1

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.5-Rep2

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.5-Rep2

text: Human sample from Homo sapiens


293T-DNMT1 site1-crDdCBE2.5-Rep3

text: ShanghaiTech University

text: live

text: Human

text: Homo sapiens

text: 293T-DNMT1 site1-crDdCBE2.5-Rep3

text: Human sample from Homo sapiens


text: Tongji University

text: live

text: Metagenome or environmental

text: biofilm samples

text: biofilm metagenome

text: biofilm

characteristic: tmp


text: Jishou University

text: live

text: Plant

text: florescence

text: China

characteristic: ecotype

text: China: Yunnan

text: Maianthemum purpureum

text: leaf

characteristic: tissue

text: Plant sample from Maianthemum purpureum


text: Southwest University

text: live

text: MIGS/MIMS/MIMARKS.miscellaneous

text: MIMARKS.survey

text: Keywords: GSC:MIxS;MIMARKS:6.0

characteristic: description

text: colon

text: China: Chongqing

text: pig

characteristic: host

text: pig gut metagenome

text: MIMARKS Survey related sample from pig gut metagenome


text: The First Affiliated Hospital of Guangxi Medical University

text: live

text: Model organism or animal

text: China: nanning, guangxi

text: Mus musculus

text: not determined

characteristic: sex

text: liver

text: Model organism or animal sample from Mus musculus

text: control

characteristic: treatment


characteristic: External Id

characteristic: INSDC center name

text: live

text: Model organism or animal

text: pH 18hr rep1

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: pH


characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Model organism or animal

text: pH 18hr rep2

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: pH


characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Model organism or animal

text: pH 18hr rep3

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: pH


text: live

text: Model organism or animal

characteristic: NCBI submission model

characteristic: NCBI submission package

text: pH 36hr rep1

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: pH


text: live

text: Model organism or animal

characteristic: SRA accession

text: pH 36hr rep2

text: China: nanning, guangxi

text: Mus musculus

characteristic: organism

text: not determined

text: liver

text: pH


text: live

text: Model organism or animal

text: pH 36hr rep3

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

characteristic: title

text: pH


text: live

text: Model organism or animal

text: pH 72hr rep1

characteristic: ecotype

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: pH


text: live

text: Model organism or animal

text: pH 72hr rep2

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

characteristic: tissue

text: pH


text: live

text: Model organism or animal

text: pH 72hr rep3

characteristic: description

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: pH


text: live

text: Model organism or animal

text: eHx 18hr rep1

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: eHx


text: live

text: Model organism or animal

text: eHx 18hr rep2

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: eHx


text: live

text: Model organism or animal

text: eHx 18hr rep3

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: eHx


text: live

text: Model organism or animal

text: eHx 36hr rep1

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: eHx


text: live

text: Model organism or animal

text: eHx 36hr rep2

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: eHx


text: live

text: Model organism or animal

text: eHx 36hr rep3

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: eHx


text: live

text: Model organism or animal

text: eHx 72hr rep1

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: eHx


text: live

text: Model organism or animal

text: eHx 72hr rep2

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: eHx


text: live

text: Model organism or animal

text: eHx 72hr rep3

text: China: nanning, guangxi

text: Mus musculus

text: not determined

text: liver

text: eHx


text: Chengdu University of traditional Chinese medicine

text: live

text: Plant

text: 1 year

characteristic: age

text: College of Pharmacy, Chengdu University of Tranditional Chinese Medicine

characteristic: cultivar

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 1

characteristic: isolate

text: Citrus reticulata

text: Peel


characteristic: External Id

text: live

text: Plant

text: 1 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 2

text: Citrus reticulata

text: Peel


characteristic: INSDC center name

text: live

text: Plant

text: 1 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 3

text: Citrus reticulata

text: Peel


characteristic: INSDC first public

text: live

text: Plant

text: 3 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 1

text: Citrus reticulata

text: Peel


characteristic: INSDC last update

text: live

text: Plant

text: 3 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 2

text: Citrus reticulata

text: Peel


characteristic: INSDC secondary accession

text: live

text: Plant

text: 3 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 3

text: Citrus reticulata

text: Peel


text: live

characteristic: INSDC status

text: Plant

text: 5 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 1

text: Citrus reticulata

text: Peel


text: live

text: Plant

characteristic: NCBI submission model

text: 5 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 2

text: Citrus reticulata

text: Peel


text: live

text: Plant

characteristic: NCBI submission package

text: 5 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 3

text: Citrus reticulata

text: Peel


text: live

text: Plant

characteristic: SRA accession

text: 10 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 1

text: Citrus reticulata

text: Peel


text: live

text: Plant

text: 10 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 2

text: Citrus reticulata

characteristic: organism

text: Peel


text: live

text: Plant

text: 10 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 3

text: Citrus reticulata

text: Peel

characteristic: title


text: live

text: Plant

text: 15 year

text: Each sample has specificity

text: China

characteristic: ecotype

text: China: Guangdong

text: replicate = biological replicate 1

text: Citrus reticulata

text: Peel


text: live

text: Plant

text: 15 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 2

text: Citrus reticulata

text: Peel

characteristic: tissue


text: live

text: Plant

text: 15 year

text: Each sample has specificity

characteristic: description

text: China

text: China: Guangdong

text: replicate = biological replicate 3

text: Citrus reticulata

text: Peel


text: live

text: Plant

text: 30 year

characteristic: age

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 1

text: Citrus reticulata

text: Peel


text: live

text: Plant

text: 30 year

characteristic: cultivar

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 2

text: Citrus reticulata

text: Peel


text: live

text: Plant

text: 30 year

text: Each sample has specificity

text: China

text: China: Guangdong

text: replicate = biological replicate 3

characteristic: isolate

text: Citrus reticulata

text: Peel


name: K562 ddCas9 RSTP2 clone5 treated with 1 uM PAO

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 1 µM PAO in positions A01, A12, E01 & E12, in plate 1 & 2

text: 1 µM PAO

characteristic: drug

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Belinostat (PXD101)

text: Netherlands Cancer Institute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Belinostat (PXD101) in position A02 in plate 1

text: 100 nM Belinostat (PXD101)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Danusertib (PHA-739358)

text: Netherlands Cancer Institute

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Danusertib (PHA-739358) in position A03 in plate 1

text: 100 nM Danusertib (PHA-739358)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM SNS-314 Mesylate

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM SNS-314 Mesylate in position A04 in plate 1

text: 100 nM SNS-314 Mesylate

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM JNJ-7706621

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM JNJ-7706621 in position A05 in plate 1

characteristic: description

text: 100 nM JNJ-7706621

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM CCT129202

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM CCT129202 in position A06 in plate 1

text: 100 nM CCT129202

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM AG-14361

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM AG-14361 in position A07 in plate 1

text: 100 nM AG-14361

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Tubastatin A HCl

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Tubastatin A HCl in position A08 in plate 1

text: 100 nM Tubastatin A HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM CUDC-907

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM CUDC-907 in position A09 in plate 1

text: 100 nM CUDC-907

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM CI994 (Tacedinaline)

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM CI994 (Tacedinaline) in position A10 in plate 1

text: 100 nM CI994 (Tacedinaline)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Entacapone

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Entacapone in position A11 in plate 1

text: 100 nM Entacapone

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 1:1000 DMSO

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 1:1000 DMSO in positions B01, B12, F01 & F12, in plate 1 & 2

text: 1:1000 DMSO

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Iniparib (BSI-201)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Iniparib (BSI-201) in position B02 in plate 1

text: 100 nM Iniparib (BSI-201)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Mocetinostat (MGCD0103)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Mocetinostat (MGCD0103) in position B03 in plate 1

characteristic: description

text: 100 nM Mocetinostat (MGCD0103)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Valproic acid sodium salt (Sodium valproate)

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Ruxolitinib (INCB018424)

text: Netherlands Cancer Institute

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Ruxolitinib (INCB018424) in position B05 in plate 1

text: 100 nM Ruxolitinib (INCB018424)

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Hesperadin

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Hesperadin in position B06 in plate 1

text: 100 nM Hesperadin

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM LY2784544

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM LY2784544 in position B07 in plate 1

text: 100 nM LY2784544

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM NVP-BSK805 2HCl

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM NVP-BSK805 2HCl in position B08 in plate 1

text: 100 nM NVP-BSK805 2HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM MK-5108 (VX-689)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM MK-5108 (VX-689) in position B09 in plate 1

text: 100 nM MK-5108 (VX-689)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM RG108

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM RG108 in position B10 in plate 1

text: 100 nM RG108

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Sodium Phenylbutyrate

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Sodium Phenylbutyrate in position B11 in plate 1

text: 100 nM Sodium Phenylbutyrate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 1 uM Mirin

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 1 µM Mirin in positions C01, C12, G01 & G12, in plate 1 & 2

characteristic: description

text: 1 µM Mirin

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM PCI-24781 (Abexinostat)

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM PCI-24781 (Abexinostat) in position C02 in plate 1

text: 100 nM PCI-24781 (Abexinostat)

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM SRT1720

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM SRT1720 in position C03 in plate 1

text: 100 nM SRT1720

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM CYC116

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM CYC116 in position C04 in plate 1

text: 100 nM CYC116

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Resveratrol

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Resveratrol in position C05 in plate 1

text: 100 nM Resveratrol

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM EX 527 (Selisistat)

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM EX 527 (Selisistat) in position C06 in plate 1

text: 100 nM EX 527 (Selisistat)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM SGI-1776 free base

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM SGI-1776 free base in position C07 in plate 1

text: 100 nM SGI-1776 free base

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM TG101209

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM TG101209 in position C08 in plate 1

text: 100 nM TG101209

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM M344

text: Netherlands Cancer Institute

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM M344 in position C09 in plate 1

text: 100 nM M344

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Baricitinib (LY3009104, INCB028050)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1

characteristic: description

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Tranylcypromine (2-PCPA) HCl

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1

text: 100 nM Tranylcypromine (2-PCPA) HCl

text: patient with chronic myelogenous leukemia (CML)

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 1 uM DNA-PKi

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 1 µM DNA-PKi in positions D01, D12, H01 & H12, in plate 1 & 2

text: 1 µM DNA-PKi

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM LAQ824 (Dacinostat)

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM LAQ824 (Dacinostat) in position D02 in plate 1

text: 100 nM LAQ824 (Dacinostat)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM INO-1001

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM INO-1001 in position D03 in plate 1

text: 100 nM INO-1001

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM ENMD-2076

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM ENMD-2076 in position D04 in plate 1

text: 100 nM ENMD-2076

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Droxinostat

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Droxinostat in position D05 in plate 1

text: 100 nM Droxinostat

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Azacitidine

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Azacitidine in position D06 in plate 1

text: 100 nM Azacitidine

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM AZ 960

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM AZ 960 in position D07 in plate 1

text: 100 nM AZ 960

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Resminostat

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Resminostat in position D08 in plate 1

characteristic: description

text: 100 nM Resminostat

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM I-BET151 (GSK1210151A)

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM I-BET151 (GSK1210151A) in position D09 in plate 1

text: 100 nM I-BET151 (GSK1210151A)

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM WHI-P154

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM WHI-P154 in position D10 in plate 1

text: 100 nM WHI-P154

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM 3-Aminobenzamide

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM 3-Aminobenzamide in position D11 in plate 1

text: 100 nM 3-Aminobenzamide

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Quisinostat (JNJ-26481585)

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Quisinostat (JNJ-26481585) in position E02 in plate 1

text: 100 nM Quisinostat (JNJ-26481585)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Alisertib (MLN8237)

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Alisertib (MLN8237) in position E03 in plate 1

text: 100 nM Alisertib (MLN8237)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM CUDC-101

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM CUDC-101 in position E04 in plate 1

text: 100 nM CUDC-101

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Aurora A Inhibitor I

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Aurora A Inhibitor I in position E05 in plate 1

text: 100 nM Aurora A Inhibitor I

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM PCI-34051

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM PCI-34051 in position E06 in plate 1

text: 100 nM PCI-34051

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM CYT387

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM CYT387 in position E07 in plate 1

characteristic: description

text: 100 nM CYT387

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM TAK-901

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM TAK-901 in position E08 in plate 1

text: 100 nM TAK-901

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Tofacitinib (CP-690550,Tasocitinib)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM PJ34

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM PJ34 in position E10 in plate 1

text: 100 nM PJ34

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Procainamide HCl

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Procainamide HCl in position E11 in plate 1

text: 100 nM Procainamide HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Rucaparib (AG-014699,PF-01367338)

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM AT9283

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM AT9283 in position F03 in plate 1

text: 100 nM AT9283

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Decitabine

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Decitabine in position F04 in plate 1

text: 100 nM Decitabine

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM PHA-680632

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM PHA-680632 in position F05 in plate 1

text: 100 nM PHA-680632

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM KW-2449

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM KW-2449 in position F06 in plate 1

characteristic: description

text: 100 nM KW-2449

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Tubacin

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Tubacin in position F07 in plate 1

text: 100 nM Tubacin

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM AMG-900

text: Netherlands Cancer Institute

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM AMG-900 in position F08 in plate 1

text: 100 nM AMG-900

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM WP1066

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM WP1066 in position F09 in plate 1

text: 100 nM WP1066

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM S-Ruxolitinib (INCB018424)

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM S-Ruxolitinib (INCB018424) in position F10 in plate 1

text: 100 nM S-Ruxolitinib (INCB018424)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Tofacitinib (CP-690550) Citrate

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Tofacitinib (CP-690550) Citrate in position F11 in plate 1

text: 100 nM Tofacitinib (CP-690550) Citrate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM MLN8054

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM MLN8054 in position G02 in plate 1

text: 100 nM MLN8054

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM AG-490 (Tyrphostin B42)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM AG-490 (Tyrphostin B42) in position G03 in plate 1

text: 100 nM AG-490 (Tyrphostin B42)

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM PFI-1 (PF-6405761)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM PFI-1 (PF-6405761) in position G04 in plate 1

text: 100 nM PFI-1 (PF-6405761)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM MC1568

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM MC1568 in position G05 in plate 1

characteristic: description

text: 100 nM MC1568

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM AZD1480

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM AZD1480 in position G06 in plate 1

text: 100 nM AZD1480

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM AR-42

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM AR-42 in position G07 in plate 1

text: 100 nM AR-42

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM TG101348 (SAR302503)

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM TG101348 (SAR302503) in position G08 in plate 1

text: 100 nM TG101348 (SAR302503)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Sirtinol

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Sirtinol in position G09 in plate 1

text: 100 nM Sirtinol

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM IOX2

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM IOX2 in position G10 in plate 1

text: 100 nM IOX2

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM AZD2461

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM AZD2461 in position G11 in plate 1

text: 100 nM AZD2461

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM ZM 447439

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM ZM 447439 in position H02 in plate 1

text: 100 nM ZM 447439

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Barasertib (AZD1152-HQPA)

text: Netherlands Cancer Institute

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Barasertib (AZD1152-HQPA) in position H03 in plate 1

text: 100 nM Barasertib (AZD1152-HQPA)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM 2-Methoxyestradiol (2-MeOE2)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1

characteristic: description

text: 100 nM 2-Methoxyestradiol (2-MeOE2)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Pracinostat (SB939)

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Pracinostat (SB939) in position H05 in plate 1

text: 100 nM Pracinostat (SB939)

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Givinostat (ITF2357)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Givinostat (ITF2357) in position H06 in plate 1

text: 100 nM Givinostat (ITF2357)

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Quercetin

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Quercetin in position H07 in plate 1

text: 100 nM Quercetin

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM CCT137690

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM CCT137690 in position H08 in plate 1

text: 100 nM CCT137690

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM CEP-33779

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM CEP-33779 in position H09 in plate 1

text: 100 nM CEP-33779

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Romidepsin (FK228, Depsipeptide)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1

text: 100 nM Romidepsin (FK228, Depsipeptide)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM XL019

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM XL019 in position H11 in plate 1

text: 100 nM XL019

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Zebularine

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Zebularine in position A02 in plate 2

text: 100 nM Zebularine

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM OG-L002

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM OG-L002 in position A03 in plate 2

characteristic: description

text: 100 nM OG-L002

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM TMP269

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM TMP269 in position A04 in plate 2

text: 100 nM TMP269

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM ZM 39923 HCl

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM ZM 39923 HCl in position A05 in plate 2

text: 100 nM ZM 39923 HCl

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Veliparib (ABT-888)

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Veliparib (ABT-888) in position A06 in plate 2

text: 100 nM Veliparib (ABT-888)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM CX-6258 HCl

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM CX-6258 HCl in position A07 in plate 2

text: 100 nM CX-6258 HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM 2,4-Pyridinedicarboxylic Acid

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2

text: 100 nM 2,4-Pyridinedicarboxylic Acid

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM ITSA-1

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM ITSA-1 in position A09 in plate 2

text: 100 nM ITSA-1

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM AGK2

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM AGK2 in position A10 in plate 2

text: 100 nM AGK2

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Oxamflatin

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Oxamflatin in position A11 in plate 2

text: 100 nM Oxamflatin

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM 3-Deazaneplanocin A (DZNeP)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2

characteristic: description

text: 100 nM 3-Deazaneplanocin A (DZNeP)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM SGC-CBP30

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM SGC-CBP30 in position B03 in plate 2

text: 100 nM SGC-CBP30

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM EPZ004777

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM EPZ004777 in position B04 in plate 2

text: 100 nM EPZ004777

characteristic: drug

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM SMI-4a

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM SMI-4a in position B05 in plate 2

text: 100 nM SMI-4a

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM FG-4592

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM FG-4592 in position B06 in plate 2

text: 100 nM FG-4592

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM BMN 673

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM BMN 673 in position B07 in plate 2

text: 100 nM BMN 673

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Garcinol

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Garcinol in position B08 in plate 2

text: 100 nM Garcinol

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Tranylcypromine hemisulfate

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Tranylcypromine hemisulfate in position B09 in plate 2

text: 100 nM Tranylcypromine hemisulfate

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Salermide

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Salermide in position B10 in plate 2

text: 100 nM Salermide

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Suramin 6Na

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Suramin·6Na in position B11 in plate 2

characteristic: description

text: 100 nM Suramin·6Na

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM EPZ-6438

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM EPZ-6438 in position C02 in plate 2

text: 100 nM EPZ-6438

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM MM-102

text: Netherlands Cancer Institute

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM MM-102 in position C03 in plate 2

text: 100 nM MM-102

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM OTX015

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM OTX015 in position C04 in plate 2

text: 100 nM OTX015

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM BIX 01294

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM BIX 01294 in position C05 in plate 2

text: 100 nM BIX 01294

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Panobinostat (LBH589)

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Panobinostat (LBH589) in position C06 in plate 2

text: 100 nM Panobinostat (LBH589)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM EPZ5676

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM EPZ5676 in position C07 in plate 2

text: 100 nM EPZ5676

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Splitomicin

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Splitomicin in position C08 in plate 2

text: 100 nM Splitomicin

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Valproic acid

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Valproic acid in position C09 in plate 2

text: 100 nM Valproic acid

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM MC-1293

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM MC-1293 in position C10 in plate 2

characteristic: description

text: 100 nM MC-1293

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM BML-278

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM BML-278 in position C11 in plate 2

text: 100 nM BML-278

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM C646

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM C646 in position D02 in plate 2

text: 100 nM C646

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM SGI-1027

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM SGI-1027 in position D03 in plate 2

text: 100 nM SGI-1027

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM UNC669

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM UNC669 in position D04 in plate 2

text: 100 nM UNC669

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM UPF 1069

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM UPF 1069 in position D05 in plate 2

text: 100 nM UPF 1069

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Trichostatin A (TSA)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Trichostatin A (TSA) in position D06 in plate 2

text: 100 nM Trichostatin A (TSA)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM GSK J4 HCl

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM GSK J4 HCl in position D07 in plate 2

text: 100 nM GSK J4 HCl

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM BML-210

text: Netherlands Cancer Institute

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM BML-210 in position D08 in plate 2

text: 100 nM BML-210

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Nicotinamide

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Nicotinamide in position D09 in plate 2

characteristic: description

text: 100 nM Nicotinamide

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Anacardic acid

characteristic: External Id

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Anacardic acid in position D10 in plate 2

text: 100 nM Anacardic acid

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM NCH-51

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM NCH-51 in position D11 in plate 2

text: 100 nM NCH-51

characteristic: drug

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM I-BET-762

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM I-BET-762 in position E02 in plate 2

text: 100 nM I-BET-762

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM RG2833 (RGFP109)

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM RG2833 (RGFP109) in position E03 in plate 2

text: 100 nM RG2833 (RGFP109)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM ME0328

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM ME0328 in position E04 in plate 2

text: 100 nM ME0328

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 100 nM Scriptaid

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 100 nM Scriptaid in position E05 in plate 2

text: 100 nM Scriptaid

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens